MICROGYNON 20 ED is a PRESCRIPTION MEDICINE for oral contraception. The memo-pack holds 21 tablets containing 20mcg ethinylestradiol and 100mcg levonorgestrel and there are 7 large placebo tablets.
MICROGYNON 20ED must not be taken during pregnancy, it should not be taken by women with a history of blood clots or by women with known or suspected cancers that may be affected by sex hormones.
MICROGYNON 20 ED should also not be taken by women with severe diabetes or liver disease or women who have a medical condition that is known to deteriorate with pregnancy. Before starting MICROGYNON 20ED a thorough medical and gynaecological examination is required. One tablet of
MICROGYNON 20ED is taken daily for 28 days starting in the green section of the pack and finishing in the gold section with the placebo tablets. The next pack must be started the following day in the same way.
A delay of more than 12 hours in taking a hormonal tablet will affect the contraceptive protection and the instructions for missed tablets must be followed. In the case of missed tablets, at least 7 days of taking hormone tablets are required to provide contraceptive protection and barrier methods must be used during this time.
During the first few months of use spotting (breakthrough bleeding), breast tenderness, nausea, bloating or headaches may occur but usually disappear with time.
If these or other side effects continue see your doctor. You should see your doctor urgently, if you are taking MICROGYNON 20ED and you develop migraines or unusually severe headaches or you get a blood clot (warning signs - sudden shortness of breath, unusual pains in your arms or legs).
MICROGYNON 20ED is distributed by Schering (NZ) Ltd P.O. Box 101 691 NSMC, Auckland.
